About CAREN PHARMACEUTICALS, INC.
Caren Pharma develops hormone-based therapeutics for age-related diseases, focusing on cognitive decline driven by aging biology. The company reformulates clinically validated agents into novel treatments targeting the biological drivers of cognitive decline.
Development of hormone-based therapeutics for age-related diseasesReformulation of clinically validated agents into novel treatmentsTargeting biological drivers of cognitive declineLeveraging FDA-approved drugs for repurposing in age-related memory loss
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to CAREN PHARMACEUTICALS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.